Reports

Industry Research Reports

description

Part 1

description

Part 2

description

Part 3

description

Part 4

description

Part 5

Home > Reports > Medical Care > Metabolic Syndrome - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Metabolic Syndrome - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Metabolic Syndrome - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Care

Published: 2024-01-24

Pages: 133 Pages

Report ld: 2332836

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Description

Metabolic syndrome is a cluster of conditions — increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol or triglyceride levels — that occur together, increasing your risk of heart disease, stroke and diabetes.

The global market for Metabolic Syndrome was estimated to be worth US$ 23890 million in 2023 and is forecast to a readjusted size of US$ 34940 million by 2030 with a CAGR of 5.1% during the forecast period 2024-2030

Metabolic Syndrome Market Size(US$)

M= millions and B=billions

QYRLogo
One of the upcoming trends gaining traction in the market is the increasing focus on oral insulin therapies. Till now, insulin injections were mostly administered through subcutaneous tissues, but this route of application is associated with risk of infection and hypersensitivity reactions, emboli, high cost, and injection site pain. Also, several needle-phobic individuals hesitate to adopt this route of administration. This paved the way for extensive research in the development of oral insulin. The oral form of insulin prevents the unpleasantness of insulin injections and other complications associated with the existing therapies. Moreover, oral administration of insulin ensures increased patient comfort and compliance, reduced risk of infection, simpler application, and is cost-effective.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Metabolic Syndrome, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Metabolic Syndrome by region & country, by Type, and by Application.

The Metabolic Syndrome market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metabolic Syndrome.

Market Segmentation

  • Report Metric

  • Details

  • Report Title

  • Metabolic Syndrome - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

  • Forecasted Market Size in 2030

  • US$ 34940 million

  • CAGR(2024-2030)

  • 5.1%

  • Market Size Available for Years

  • 2024-2030

  • Global Metabolic Syndrome Companies Covered

  • Novo Nordisk

    Sanofi

    Merck

    AstraZeneca

    Eli Lily

    AbbVie

    Actelion Pharmaceuticals

    Adocia

    Aegerion Pharmaceuticals

    Akros Pharma

    Alnylam Pharmaceuticals

    Amarin

    nAmgen

    Amicus Therapeutics

    Arbutus Biopharma

  • Global Metabolic Syndrome Market, by Region

  • North America (U.S., Canada, Mexico)

    Europe (Germany, France, UK, Italy, etc.)

    Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

    South America (Brazil, etc.)

    Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

  • Global Metabolic Syndrome Market, Segment by Type

  • Diabetes

    Obesity

    Hypercholesterolemia

    Lysosomal storage diseases

  • Global Metabolic Syndrome Market, Segment by Application

  • Hospital

    Clinic

    Others

  • Forecast Units

  • Million USD

  • Report Coverage

  • Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Metabolic Syndrome manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Metabolic Syndrome in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Metabolic Syndrome in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

1 Market Overview
    1.1 Metabolic Syndrome Product Introduction
    1.2 Global Metabolic Syndrome Market Size Forecast
    1.3 Metabolic Syndrome Market Trends & Drivers
        1.3.1 Metabolic Syndrome Industry Trends
        1.3.2 Metabolic Syndrome Market Drivers & Opportunity
        1.3.3 Metabolic Syndrome Market Challenges
        1.3.4 Metabolic Syndrome Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered
2 Competitive Analysis by Company
    2.1 Global Metabolic Syndrome Players Revenue Ranking (2023)
    2.2 Global Metabolic Syndrome Revenue by Company (2019-2024)
    2.3 Key Companies Metabolic Syndrome Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Metabolic Syndrome Product Offered
    2.5 Key Companies Time to Begin Mass Production of Metabolic Syndrome
    2.6 Metabolic Syndrome Market Competitive Analysis
        2.6.1 Metabolic Syndrome Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Metabolic Syndrome Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabolic Syndrome as of 2023)
    2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Diabetes
        3.1.2 Obesity
        3.1.3 Hypercholesterolemia
        3.1.4 Lysosomal storage diseases
    3.2 Global Metabolic Syndrome Sales Value by Type
        3.2.1 Global Metabolic Syndrome Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Metabolic Syndrome Sales Value, by Type (2019-2030)
        3.2.3 Global Metabolic Syndrome Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospital
        4.1.2 Clinic
        4.1.3 Others
    4.2 Global Metabolic Syndrome Sales Value by Application
        4.2.1 Global Metabolic Syndrome Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Metabolic Syndrome Sales Value, by Application (2019-2030)
        4.2.3 Global Metabolic Syndrome Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
    5.1 Global Metabolic Syndrome Sales Value by Region
        5.1.1 Global Metabolic Syndrome Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Metabolic Syndrome Sales Value by Region (2019-2024)
        5.1.3 Global Metabolic Syndrome Sales Value by Region (2025-2030)
        5.1.4 Global Metabolic Syndrome Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Metabolic Syndrome Sales Value, 2019-2030
        5.2.2 North America Metabolic Syndrome Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Metabolic Syndrome Sales Value, 2019-2030
        5.3.2 Europe Metabolic Syndrome Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Metabolic Syndrome Sales Value, 2019-2030
        5.4.2 Asia Pacific Metabolic Syndrome Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Metabolic Syndrome Sales Value, 2019-2030
        5.5.2 South America Metabolic Syndrome Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Metabolic Syndrome Sales Value, 2019-2030
        5.6.2 Middle East & Africa Metabolic Syndrome Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Metabolic Syndrome Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Metabolic Syndrome Sales Value
    6.3 United States
        6.3.1 United States Metabolic Syndrome Sales Value, 2019-2030
        6.3.2 United States Metabolic Syndrome Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Metabolic Syndrome Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Metabolic Syndrome Sales Value, 2019-2030
        6.4.2 Europe Metabolic Syndrome Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Metabolic Syndrome Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Metabolic Syndrome Sales Value, 2019-2030
        6.5.2 China Metabolic Syndrome Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Metabolic Syndrome Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Metabolic Syndrome Sales Value, 2019-2030
        6.6.2 Japan Metabolic Syndrome Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Metabolic Syndrome Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Metabolic Syndrome Sales Value, 2019-2030
        6.7.2 South Korea Metabolic Syndrome Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Metabolic Syndrome Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Metabolic Syndrome Sales Value, 2019-2030
        6.8.2 Southeast Asia Metabolic Syndrome Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Metabolic Syndrome Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Metabolic Syndrome Sales Value, 2019-2030
        6.9.2 India Metabolic Syndrome Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Metabolic Syndrome Sales Value by Application, 2023 VS 2030
7 Company Profiles
    7.1 Novo Nordisk
        7.1.1 Novo Nordisk Profile
        7.1.2 Novo Nordisk Main Business
        7.1.3 Novo Nordisk Metabolic Syndrome Products, Services and Solutions
        7.1.4 Novo Nordisk Metabolic Syndrome Revenue (US$ Million) & (2019-2024)
        7.1.5 Novo Nordisk Recent Developments
    7.2 Sanofi
        7.2.1 Sanofi Profile
        7.2.2 Sanofi Main Business
        7.2.3 Sanofi Metabolic Syndrome Products, Services and Solutions
        7.2.4 Sanofi Metabolic Syndrome Revenue (US$ Million) & (2019-2024)
        7.2.5 Sanofi Recent Developments
    7.3 Merck
        7.3.1 Merck Profile
        7.3.2 Merck Main Business
        7.3.3 Merck Metabolic Syndrome Products, Services and Solutions
        7.3.4 Merck Metabolic Syndrome Revenue (US$ Million) & (2019-2024)
        7.3.5 AstraZeneca Recent Developments
    7.4 AstraZeneca
        7.4.1 AstraZeneca Profile
        7.4.2 AstraZeneca Main Business
        7.4.3 AstraZeneca Metabolic Syndrome Products, Services and Solutions
        7.4.4 AstraZeneca Metabolic Syndrome Revenue (US$ Million) & (2019-2024)
        7.4.5 AstraZeneca Recent Developments
    7.5 Eli Lily
        7.5.1 Eli Lily Profile
        7.5.2 Eli Lily Main Business
        7.5.3 Eli Lily Metabolic Syndrome Products, Services and Solutions
        7.5.4 Eli Lily Metabolic Syndrome Revenue (US$ Million) & (2019-2024)
        7.5.5 Eli Lily Recent Developments
    7.6 AbbVie
        7.6.1 AbbVie Profile
        7.6.2 AbbVie Main Business
        7.6.3 AbbVie Metabolic Syndrome Products, Services and Solutions
        7.6.4 AbbVie Metabolic Syndrome Revenue (US$ Million) & (2019-2024)
        7.6.5 AbbVie Recent Developments
    7.7 Actelion Pharmaceuticals
        7.7.1 Actelion Pharmaceuticals Profile
        7.7.2 Actelion Pharmaceuticals Main Business
        7.7.3 Actelion Pharmaceuticals Metabolic Syndrome Products, Services and Solutions
        7.7.4 Actelion Pharmaceuticals Metabolic Syndrome Revenue (US$ Million) & (2019-2024)
        7.7.5 Actelion Pharmaceuticals Recent Developments
    7.8 Adocia
        7.8.1 Adocia Profile
        7.8.2 Adocia Main Business
        7.8.3 Adocia Metabolic Syndrome Products, Services and Solutions
        7.8.4 Adocia Metabolic Syndrome Revenue (US$ Million) & (2019-2024)
        7.8.5 Adocia Recent Developments
    7.9 Aegerion Pharmaceuticals
        7.9.1 Aegerion Pharmaceuticals Profile
        7.9.2 Aegerion Pharmaceuticals Main Business
        7.9.3 Aegerion Pharmaceuticals Metabolic Syndrome Products, Services and Solutions
        7.9.4 Aegerion Pharmaceuticals Metabolic Syndrome Revenue (US$ Million) & (2019-2024)
        7.9.5 Aegerion Pharmaceuticals Recent Developments
    7.10 Akros Pharma
        7.10.1 Akros Pharma Profile
        7.10.2 Akros Pharma Main Business
        7.10.3 Akros Pharma Metabolic Syndrome Products, Services and Solutions
        7.10.4 Akros Pharma Metabolic Syndrome Revenue (US$ Million) & (2019-2024)
        7.10.5 Akros Pharma Recent Developments
    7.11 Alnylam Pharmaceuticals
        7.11.1 Alnylam Pharmaceuticals Profile
        7.11.2 Alnylam Pharmaceuticals Main Business
        7.11.3 Alnylam Pharmaceuticals Metabolic Syndrome Products, Services and Solutions
        7.11.4 Alnylam Pharmaceuticals Metabolic Syndrome Revenue (US$ Million) & (2019-2024)
        7.11.5 Alnylam Pharmaceuticals Recent Developments
    7.12 Amarin
        7.12.1 Amarin Profile
        7.12.2 Amarin Main Business
        7.12.3 Amarin Metabolic Syndrome Products, Services and Solutions
        7.12.4 Amarin Metabolic Syndrome Revenue (US$ Million) & (2019-2024)
        7.12.5 Amarin Recent Developments
    7.13 nAmgen
        7.13.1 nAmgen Profile
        7.13.2 nAmgen Main Business
        7.13.3 nAmgen Metabolic Syndrome Products, Services and Solutions
        7.13.4 nAmgen Metabolic Syndrome Revenue (US$ Million) & (2019-2024)
        7.13.5 nAmgen Recent Developments
    7.14 Amicus Therapeutics
        7.14.1 Amicus Therapeutics Profile
        7.14.2 Amicus Therapeutics Main Business
        7.14.3 Amicus Therapeutics Metabolic Syndrome Products, Services and Solutions
        7.14.4 Amicus Therapeutics Metabolic Syndrome Revenue (US$ Million) & (2019-2024)
        7.14.5 Amicus Therapeutics Recent Developments
    7.15 Arbutus Biopharma
        7.15.1 Arbutus Biopharma Profile
        7.15.2 Arbutus Biopharma Main Business
        7.15.3 Arbutus Biopharma Metabolic Syndrome Products, Services and Solutions
        7.15.4 Arbutus Biopharma Metabolic Syndrome Revenue (US$ Million) & (2019-2024)
        7.15.5 Arbutus Biopharma Recent Developments
8 Industry Chain Analysis
    8.1 Metabolic Syndrome Industrial Chain
    8.2 Metabolic Syndrome Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Metabolic Syndrome Sales Model
        8.5.2 Sales Channel
        8.5.3 Metabolic Syndrome Distributors
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Metabolic Syndrome Market Trends
    Table 2. Metabolic Syndrome Market Drivers & Opportunity
    Table 3. Metabolic Syndrome Market Challenges
    Table 4. Metabolic Syndrome Market Restraints
    Table 5. Global Metabolic Syndrome Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Metabolic Syndrome Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Metabolic Syndrome Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Metabolic Syndrome Product Type
    Table 9. Key Companies Time to Begin Mass Production of Metabolic Syndrome
    Table 10. Global Metabolic Syndrome Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabolic Syndrome as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Metabolic Syndrome Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Metabolic Syndrome Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Metabolic Syndrome Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Metabolic Syndrome Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Metabolic Syndrome Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Metabolic Syndrome Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Metabolic Syndrome Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Metabolic Syndrome Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Metabolic Syndrome Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Metabolic Syndrome Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Metabolic Syndrome Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Metabolic Syndrome Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Metabolic Syndrome Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Metabolic Syndrome Sales Value by Region (2019-2024) & (%)
    Table 27. Global Metabolic Syndrome Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Metabolic Syndrome Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Metabolic Syndrome Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Metabolic Syndrome Sales Value, (2025-2030) & (US$ Million)
    Table 31. Novo Nordisk Basic Information List
    Table 32. Novo Nordisk Description and Business Overview
    Table 33. Novo Nordisk Metabolic Syndrome Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Metabolic Syndrome Business of Novo Nordisk (2019-2024)
    Table 35. Novo Nordisk Recent Developments
    Table 36. Sanofi Basic Information List
    Table 37. Sanofi Description and Business Overview
    Table 38. Sanofi Metabolic Syndrome Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Metabolic Syndrome Business of Sanofi (2019-2024)
    Table 40. Sanofi Recent Developments
    Table 41. Merck Basic Information List
    Table 42. Merck Description and Business Overview
    Table 43. Merck Metabolic Syndrome Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Metabolic Syndrome Business of Merck (2019-2024)
    Table 45. Merck Recent Developments
    Table 46. AstraZeneca Basic Information List
    Table 47. AstraZeneca Description and Business Overview
    Table 48. AstraZeneca Metabolic Syndrome Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Metabolic Syndrome Business of AstraZeneca (2019-2024)
    Table 50. AstraZeneca Recent Developments
    Table 51. Eli Lily Basic Information List
    Table 52. Eli Lily Description and Business Overview
    Table 53. Eli Lily Metabolic Syndrome Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Metabolic Syndrome Business of Eli Lily (2019-2024)
    Table 55. Eli Lily Recent Developments
    Table 56. AbbVie Basic Information List
    Table 57. AbbVie Description and Business Overview
    Table 58. AbbVie Metabolic Syndrome Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Metabolic Syndrome Business of AbbVie (2019-2024)
    Table 60. AbbVie Recent Developments
    Table 61. Actelion Pharmaceuticals Basic Information List
    Table 62. Actelion Pharmaceuticals Description and Business Overview
    Table 63. Actelion Pharmaceuticals Metabolic Syndrome Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Metabolic Syndrome Business of Actelion Pharmaceuticals (2019-2024)
    Table 65. Actelion Pharmaceuticals Recent Developments
    Table 66. Adocia Basic Information List
    Table 67. Adocia Description and Business Overview
    Table 68. Adocia Metabolic Syndrome Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Metabolic Syndrome Business of Adocia (2019-2024)
    Table 70. Adocia Recent Developments
    Table 71. Aegerion Pharmaceuticals Basic Information List
    Table 72. Aegerion Pharmaceuticals Description and Business Overview
    Table 73. Aegerion Pharmaceuticals Metabolic Syndrome Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Metabolic Syndrome Business of Aegerion Pharmaceuticals (2019-2024)
    Table 75. Aegerion Pharmaceuticals Recent Developments
    Table 76. Akros Pharma Basic Information List
    Table 77. Akros Pharma Description and Business Overview
    Table 78. Akros Pharma Metabolic Syndrome Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Metabolic Syndrome Business of Akros Pharma (2019-2024)
    Table 80. Akros Pharma Recent Developments
    Table 81. Alnylam Pharmaceuticals Basic Information List
    Table 82. Alnylam Pharmaceuticals Description and Business Overview
    Table 83. Alnylam Pharmaceuticals Metabolic Syndrome Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Metabolic Syndrome Business of Alnylam Pharmaceuticals (2019-2024)
    Table 85. Alnylam Pharmaceuticals Recent Developments
    Table 86. Amarin Basic Information List
    Table 87. Amarin Description and Business Overview
    Table 88. Amarin Metabolic Syndrome Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Metabolic Syndrome Business of Amarin (2019-2024)
    Table 90. Amarin Recent Developments
    Table 91. nAmgen Basic Information List
    Table 92. nAmgen Description and Business Overview
    Table 93. nAmgen Metabolic Syndrome Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Metabolic Syndrome Business of nAmgen (2019-2024)
    Table 95. nAmgen Recent Developments
    Table 96. Amicus Therapeutics Basic Information List
    Table 97. Amicus Therapeutics Description and Business Overview
    Table 98. Amicus Therapeutics Metabolic Syndrome Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Metabolic Syndrome Business of Amicus Therapeutics (2019-2024)
    Table 100. Amicus Therapeutics Recent Developments
    Table 101. Arbutus Biopharma Basic Information List
    Table 102. Arbutus Biopharma Description and Business Overview
    Table 103. Arbutus Biopharma Metabolic Syndrome Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Metabolic Syndrome Business of Arbutus Biopharma (2019-2024)
    Table 105. Arbutus Biopharma Recent Developments
    Table 106. Key Raw Materials Lists
    Table 107. Raw Materials Key Suppliers Lists
    Table 108. Metabolic Syndrome Downstream Customers
    Table 109. Metabolic Syndrome Distributors List
    Table 110. Research Programs/Design for This Report
    Table 111. Key Data Information from Secondary Sources
    Table 112. Key Data Information from Primary Sources
    Table 113. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Metabolic Syndrome Product Picture
    Figure 2. Global Metabolic Syndrome Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Metabolic Syndrome Sales Value (2019-2030) & (US$ Million)
    Figure 4. Metabolic Syndrome Report Years Considered
    Figure 5. Global Metabolic Syndrome Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Metabolic Syndrome Revenue in 2023
    Figure 7. Metabolic Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Diabetes Picture
    Figure 9. Obesity Picture
    Figure 10. Hypercholesterolemia Picture
    Figure 11. Lysosomal storage diseases Picture
    Figure 12. Global Metabolic Syndrome Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 13. Global Metabolic Syndrome Sales Value Market Share by Type, 2023 & 2030
    Figure 14. Product Picture of Hospital
    Figure 15. Product Picture of Clinic
    Figure 16. Product Picture of Others
    Figure 17. Global Metabolic Syndrome Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 18. Global Metabolic Syndrome Sales Value Market Share by Application, 2023 & 2030
    Figure 19. North America Metabolic Syndrome Sales Value (2019-2030) & (US$ Million)
    Figure 20. North America Metabolic Syndrome Sales Value by Country (%), 2023 VS 2030
    Figure 21. Europe Metabolic Syndrome Sales Value (2019-2030) & (US$ Million)
    Figure 22. Europe Metabolic Syndrome Sales Value by Country (%), 2023 VS 2030
    Figure 23. Asia Pacific Metabolic Syndrome Sales Value (2019-2030) & (US$ Million)
    Figure 24. Asia Pacific Metabolic Syndrome Sales Value by Country (%), 2023 VS 2030
    Figure 25. South America Metabolic Syndrome Sales Value (2019-2030) & (US$ Million)
    Figure 26. South America Metabolic Syndrome Sales Value by Country (%), 2023 VS 2030
    Figure 27. Middle East & Africa Metabolic Syndrome Sales Value (2019-2030) & (US$ Million)
    Figure 28. Middle East & Africa Metabolic Syndrome Sales Value by Country (%), 2023 VS 2030
    Figure 29. Key Countries/Regions Metabolic Syndrome Sales Value (%), (2019-2030)
    Figure 30. United States Metabolic Syndrome Sales Value, (2019-2030) & (US$ Million)
    Figure 31. United States Metabolic Syndrome Sales Value by Type (%), 2023 VS 2030
    Figure 32. United States Metabolic Syndrome Sales Value by Application (%), 2023 VS 2030
    Figure 33. Europe Metabolic Syndrome Sales Value, (2019-2030) & (US$ Million)
    Figure 34. Europe Metabolic Syndrome Sales Value by Type (%), 2023 VS 2030
    Figure 35. Europe Metabolic Syndrome Sales Value by Application (%), 2023 VS 2030
    Figure 36. China Metabolic Syndrome Sales Value, (2019-2030) & (US$ Million)
    Figure 37. China Metabolic Syndrome Sales Value by Type (%), 2023 VS 2030
    Figure 38. China Metabolic Syndrome Sales Value by Application (%), 2023 VS 2030
    Figure 39. Japan Metabolic Syndrome Sales Value, (2019-2030) & (US$ Million)
    Figure 40. Japan Metabolic Syndrome Sales Value by Type (%), 2023 VS 2030
    Figure 41. Japan Metabolic Syndrome Sales Value by Application (%), 2023 VS 2030
    Figure 42. South Korea Metabolic Syndrome Sales Value, (2019-2030) & (US$ Million)
    Figure 43. South Korea Metabolic Syndrome Sales Value by Type (%), 2023 VS 2030
    Figure 44. South Korea Metabolic Syndrome Sales Value by Application (%), 2023 VS 2030
    Figure 45. Southeast Asia Metabolic Syndrome Sales Value, (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Metabolic Syndrome Sales Value by Type (%), 2023 VS 2030
    Figure 47. Southeast Asia Metabolic Syndrome Sales Value by Application (%), 2023 VS 2030
    Figure 48. India Metabolic Syndrome Sales Value, (2019-2030) & (US$ Million)
    Figure 49. India Metabolic Syndrome Sales Value by Type (%), 2023 VS 2030
    Figure 50. India Metabolic Syndrome Sales Value by Application (%), 2023 VS 2030
    Figure 51. Metabolic Syndrome Industrial Chain
    Figure 52. Metabolic Syndrome Manufacturing Cost Structure
    Figure 53. Channels of Distribution (Direct Sales, and Distribution)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation

Description

Metabolic syndrome is a cluster of conditions — increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol or triglyceride levels — that occur together, increasing your risk of heart disease, stroke and diabetes.

The global market for Metabolic Syndrome was estimated to be worth US$ 23890 million in 2023 and is forecast to a readjusted size of US$ 34940 million by 2030 with a CAGR of 5.1% during the forecast period 2024-2030
One of the upcoming trends gaining traction in the market is the increasing focus on oral insulin therapies. Till now, insulin injections were mostly administered through subcutaneous tissues, but this route of application is associated with risk of infection and hypersensitivity reactions, emboli, high cost, and injection site pain. Also, several needle-phobic individuals hesitate to adopt this route of administration. This paved the way for extensive research in the development of oral insulin. The oral form of insulin prevents the unpleasantness of insulin injections and other complications associated with the existing therapies. Moreover, oral administration of insulin ensures increased patient comfort and compliance, reduced risk of infection, simpler application, and is cost-effective.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Metabolic Syndrome, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Metabolic Syndrome by region & country, by Type, and by Application.

The Metabolic Syndrome market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metabolic Syndrome.

Market Segmentation
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Metabolic Syndrome manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Metabolic Syndrome in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Metabolic Syndrome in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Related Reports

Metabolic Syndrome - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Care

Published: 2024-01-24

Pages: 133 Pages

Report ld: 2332836

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

CHOOSE LICENSE TYPE
tip

USD 3950.00

tip

USD 5925.00

tip

USD 7900.00

Add to Cart

Add to Cart

Buy Now

Buy Now

Have a question?
SIMON LEE

English

English

SIMON LEE

+1-62 6295 2442

Online

JOHN WANG

English

English

JOHN WANG

+41 765 899 438

Offline

HITESH

English

English

HITESH

+91-86 6998 6909

Offline

TANG XIN

Japanese

Japanese

TANG XIN

+81-90 3800 9273

Offline

SUNG-BIN YOON

Korean

Korean

SUNG-BIN YOON

+82-2883 1278

Offline

YUJIE TIAN

English

English

YUJIE TIAN

+86-135-2215-3954

Offline

DAMON

Chinese

Chinese

DAMON

+86-133 1872 9947

Offline

General Email:
global@qyresearch.com
WHAT QYRESEARCH OFFER?
Competition

Competition

Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.

Industry Analysis

Industry Analysis

Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.

Market Size

Market Size

Capacity, production, sales, revenue, price, cost etc.

Customized Information

Customized Information

We can offer customized survey and information to meet ourclient's need.

INTEREST IN THIS REPORT?

Get A Free Sample >>
WHY QYR?
  • Fastest report delivery service

    Fastest report delivery service

  • More than years of vast experience

    More than years of vast experience

  • Operation for 24 * 7 & 365 days

    Operation for 24 * 7 & 365 days

  • In-depth and comprehensive analysis

    In-depth and comprehensive analysis

  • Professional and timely after-sales service

    Professional and timely after-sales service

  • Owns large database

    Owns large database

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now